Fundz

Atomo Diagnostics Appoints Dr Cheri Walker as Interim CEO

PRIVATEAug 19, 2026

Position

Chief Executive Officer

Company

Atomo Diagnostics

Cheri Walker
ManufacturingBiotechnologyHealth Care

Description

Atomo Diagnostics has appointed Dr Cheri Walker as interim CEO, effective immediately, following the resignation of John Kelly. This leadership change aligns with the company's focus on expanding its international commercial presence.

Quick answer

Atomo Diagnostics Appoints Dr Cheri Walker as Interim CEO (August 19, 2026).

Who is the new Chief Executive Officer at Atomo Diagnostics?
Atomo Diagnostics named Cheri Walker Chief Executive Officer, announced August 19, 2026.
What did Atomo Diagnostics announce on August 19, 2026?
Atomo Diagnostics has appointed Dr Cheri Walker as interim CEO, effective immediately, following the resignation of John Kelly. This leadership change aligns with the company's focus on expanding its international commercial presence.
What does Atomo Diagnostics do?
Atomo Diagnostics is a publicly listed diagnostics company focused on developing innovative diagnostic solutions.
Which similar companies made leadership changes around the same time?
ChronoScale Holdings Corp (August 18, 2026), Baxter International (August 19, 2026), Orchestra Life Sciences (August 18, 2026) and Unichem Laboratories Limited (August 18, 2026) also announced leadership changes within 45 days of Atomo Diagnostics.

Source: Fundz verified event record.

Other recent leadership changes in Manufacturing and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Atomo Diagnostics, and when

A new leader at Atomo Diagnostics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Atomo Diagnostics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Atomo Diagnostics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Atomo Diagnostics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Atomo Diagnostics

About

Atomo Diagnostics is a publicly listed diagnostics company focused on developing innovative diagnostic solutions. The company emphasizes international commercial activities, particularly in the United States and Europe. They are transitioning their leadership to align with their evolving business needs. Atomo aims to build a proprietary product pipeline for both professional and consumer use.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Atomo Diagnostics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Atomo Diagnostics's next move

Learn about Strategic plan

Atomo Diagnostics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.